← Open Payments lookup

MATTHEW GILL: Open Payments

NPI 1114251238 · COLLINSVILLE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$515 in 31 payments from 15 companies in 2025. Trend: 2023 $84 · 2024 $270 · 2025 $515

Food & beverage: $515
CompanyPaymentsAmount
ABBVIE INC.5$91
Lilly USA, LLC6$89
AstraZeneca Pharmaceuticals LP3$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$44
Bayer Healthcare Pharmaceuticals Inc.2$35
Takeda Pharmaceuticals U.S.A., Inc.2$31
Novo Nordisk Inc2$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$26
Janssen Pharmaceuticals, Inc1$21
Dexcom, Inc.1$19

Products named: MOUNJARO, VRAYLAR, CAPLYTA, Kerendia, TRINTELLIX, Ozempic, XIFAXAN, LINZESS.

Industry payments across OK — which companies pay providers there.